[1] Jagdish RK,Maras JS,Sarin SK. Albumin in Advanced Liver Diseases: The Good and Bad of a Drug！Hepatology,2021,74:2848-2862.
[2] Bernardi M,Angeli P,Claria J,et al. Albumin in decompensated cirrhosis: new concepts and perspectives. Gut,2020,69:1127-1138.
[3] Bernardi M, Caraceni P. Novel perspectives in the management of decompensated cirrhosis. Nat Rev Gastroenterol Hepatol,2018,15:753-764.
[4] Vairappan B. Endothelial dysfunction in cirrhosis:Role of inflammation and oxidative stress.World J Hepatol,2015,7:443-459.
[5] Jalan R,Bernardi M. Effective albumin concentration and cirrhosis mortality: from concept to reality. J Hepatol,2013,59:918-920.
[6] Arora V,Vijayaraghavan R,Maiwall R,et al.Paracentesis-Induced Circulatory Dysfunction With Modest-Volume Paracentesis Is Partly Ameliorated by Albumin In fusion in Acute-on-Chronic Liver Failure. Hepatology,2020,72:1043-1055.
[7] Maiwall R,Pasupuleti SSR,Bihari C,et al. Incidence,Risk Factors,and Outcomes of Transition of Acute Kidney Injury to Chronic Kidney Disease in Cirrhosis: A Prospective Cohort Study.Hepatology,2020,71:1009-1022.
[8] Aithal G,Palaniyappan N,China L,et al.Guidelines on the management of ascites in cirrhosis.Gut,2021,70:9-29.
[9] Alukal JJ,John S,Thuluvath PJ. Hyponatremiain Cirrhosis:An Update. Am J Gastroenterol,2020,115:1775-1785.
[10] Caraceni P, Riggio O, Angeli P, et al. Long-term albumin administration in decompensated cirrhosis(ANSWER):an open-label randomized trial. Lancet, 2018,391:2417-2429.
[11] China L,Freemantle N,Forrest E,et al. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis. N Engl J Med,2021,384:808-817.
[12] China L,Freemantle N,Forrest E,et al. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis. N Engl J Med,2021,384:808-817.
[13] Thevenot T, Bureau C, Oberti F, et al. Effect of albuminin cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial. J Hepatol,2015,62:822-830.
[14] Fernandez J,Angeli P,Trebicka J,et al. Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. Clin Gastroenterol Hepatol,2020,18:963-973.
[15] Philips CA,Maiwall R,Sharma MK,et al. Comparison of 5%human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis(FRISC study):a randomized controlled trial. Hepatol Int,2021,15:983-994.
[16] Maiwall R,Maras JS,Nayak SL,et al. Liver dialysis in acute-on-chronic liver failure:current and future perspectives. Hepatol Int,2014,8 Suppl2:505-513.
[17] Fernandez J,Claria J,Amoros A,et al. Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis. Gastroenterology,2019,157:149-162.
[18] Caraceni P, Tufoni M, Zaccherini G, et al. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites. J Hepatol,2021,74(2):340-349. |
